Come meet and network with Life Science Deal Flow and OnBioVC at our Office Hours on 08 July in Cambridge, MA. For details on oHours (time/place) and to sign-up for a time slot visit HERE. We look forward to connecting with you! [Trouble with the oHours sign-up link? Then paste this url in your browser [...]

• 801http://clsdf.com/2011/06/visit-with-life-science-deal-flow-at-office-hours/Visit+with+Life+Science+Deal+Flow+at+Office+Hours%212011-06-20+13%3A30%3A38admin

Our Life Science Deal Flow PDUFA Trade Strategy is not applicable to just any approaching date. There are several dates this month; Celgene’s (Nasdaq: CELG) istodax®, for relapsed and refractory peripheral T-cell lymphoma, Acura Pharmaceutical’s (Nasdaq: ACUR) acurox®, an abuse-resistant pain med, and Fibrorcell Science’s (Nasdaq: FCSC) iaviv®, for the treatment of moderate to serve [...]

• 795http://clsdf.com/2011/06/one-size-pdufa-trade-opportunity-does-not-fit-all/One+Size+PDUFA-Trade+Opportunity+Does+Not+Fit+All2011-06-17+05%3A07%3A41admin

On a day when the markets were hammered, with the Dow, S&P and Nasdaq all down over 2%, it is pleasure to reveal that our Optimer Pharmaceuticals (Nasdaq: OPTR) trade worked out, just as we drew it up on the whiteboard! Why did it work? Well it was not simply a function of the Company [...]

• 785http://clsdf.com/2011/06/booyah-optimer-optr-trade-is-a-winner/Booyah%21+Optimer+%28OPTR%29+Trade+is+a+Winner%212011-06-02+03%3A36%3A09admin